| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9233184 | HISAMITSU PHARM CO | Adhesive preparation |
Aug, 2027
(3 years from now) | |
| US8809615 | HISAMITSU PHARM CO | Adhesive preparation |
Jan, 2030
(6 years from now) | |
Salonpas is owned by Hisamitsu Pharm Co.
Salonpas contains Menthol; Methyl Salicylate.
Salonpas has a total of 2 drug patents out of which 0 drug patents have expired.
Salonpas was authorised for market use on 20 February, 2008.
Salonpas is available in patch;topical dosage forms.
The generics of Salonpas are possible to be released after 03 January, 2030.
Drugs and Companies using MENTHOL; METHYL SALICYLATE ingredient
Market Authorisation Date: 20 February, 2008
Treatment: NA
Dosage: PATCH;TOPICAL
More Information on Dosage
SALONPAS family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic